Huang Zhiwei, Hu Fenghuan, Liu Haibo, Wang Man
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Bejing, China (mainland).
Med Sci Monit. 2022 Mar 19;28:e934703. doi: 10.12659/MSM.934703.
BACKGROUND This retrospective study aimed to compare the effects of methylprednisolone and dexamethasone in 35 patients with anaphylactic shock due to iodinated contrast media (ICM) during cardiac catheterization. MATERIAL AND METHODS Thirty-five patients diagnosed with ICM-related anaphylactic shock were enrolled. Nineteen patients received methylprednisolone, while 16 patients received dexamethasone. RESULTS The mean age of patients was 59.8 years in the methylprednisolone group and 57.2 years in the dexamethasone group (P=0.502). Most patients were male (82.9% [26/35]). The groups were matched for cardiac function, kidney function, comorbidities, prior contrast, previous radiocontrast media reactions, and allergic tendencies (all P>0.05). The severity of coronary artery disease, assessed using the SYNTAX II score, was similar between groups (P=0.620). Six patients died from ICM-induced anaphylactic shock. There was no significant difference in mortality between the 2 groups (P=1.000). CONCLUSIONS There was no significant difference in patient mortality from anaphylactic shock associated with ICM during cardiac catheterization between the methylprednisolone and dexamethasone groups.
背景 本回顾性研究旨在比较甲基强的松龙和地塞米松对35例在心脏导管插入术期间因碘化造影剂(ICM)导致过敏性休克患者的疗效。材料与方法 纳入35例诊断为与ICM相关过敏性休克的患者。19例患者接受甲基强的松龙治疗,16例患者接受地塞米松治疗。结果 甲基强的松龙组患者的平均年龄为59.8岁,地塞米松组为57.2岁(P = 0.502)。大多数患者为男性(82.9%[26/35])。两组在心脏功能、肾功能、合并症、既往造影剂使用情况、既往放射造影剂反应和过敏倾向方面相匹配(所有P>0.05)。使用SYNTAX II评分评估的冠状动脉疾病严重程度在两组之间相似(P = 0.620)。6例患者死于ICM引起的过敏性休克。两组之间的死亡率无显著差异(P = 1.000)。结论 在心脏导管插入术期间,甲基强的松龙组和地塞米松组因ICM相关过敏性休克导致的患者死亡率无显著差异。